全文获取类型
收费全文 | 551篇 |
免费 | 28篇 |
国内免费 | 67篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 26篇 |
妇产科学 | 10篇 |
基础医学 | 61篇 |
口腔科学 | 8篇 |
临床医学 | 86篇 |
内科学 | 89篇 |
皮肤病学 | 13篇 |
神经病学 | 34篇 |
特种医学 | 138篇 |
外科学 | 24篇 |
综合类 | 27篇 |
预防医学 | 39篇 |
眼科学 | 4篇 |
药学 | 63篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 3篇 |
2022年 | 3篇 |
2021年 | 8篇 |
2020年 | 2篇 |
2019年 | 2篇 |
2018年 | 4篇 |
2016年 | 5篇 |
2015年 | 8篇 |
2014年 | 10篇 |
2013年 | 16篇 |
2012年 | 8篇 |
2011年 | 9篇 |
2010年 | 26篇 |
2009年 | 28篇 |
2008年 | 12篇 |
2007年 | 61篇 |
2006年 | 15篇 |
2005年 | 11篇 |
2004年 | 12篇 |
2003年 | 15篇 |
2002年 | 11篇 |
2001年 | 6篇 |
2000年 | 13篇 |
1999年 | 7篇 |
1998年 | 23篇 |
1997年 | 35篇 |
1996年 | 25篇 |
1995年 | 23篇 |
1994年 | 21篇 |
1993年 | 20篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 13篇 |
1989年 | 15篇 |
1988年 | 21篇 |
1987年 | 14篇 |
1986年 | 9篇 |
1985年 | 15篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 7篇 |
1980年 | 9篇 |
1979年 | 3篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1975年 | 10篇 |
1960年 | 3篇 |
1871年 | 3篇 |
排序方式: 共有646条查询结果,搜索用时 265 毫秒
641.
本文目的旨在观察硫酸锌对心肌慢反应电活动的影响,所得结果如下:(1) 0.1~0.3mmol硫酸锌能使高钾除极引起的豚鼠乳头肌慢反应动作电位APA和Vmax降低,APD50和APD90)显著延长;(2) 0.1~0.3 mmol硫酸锌能抑制家兔离体窦房结细胞的自律性,使窦房结APA降低,APD90延长,SP0和SP4减小;(3) 0.1 mmol硫酸锌可对抗0.4μmol哇巴因诱发的豚鼠心室肌振荡后电位,提高引起振荡后电位的哇巴因阈浓度。提示:锌抑制心肌慢反应电活动。 相似文献
642.
643.
清热中药对大鼠下丘脑组织AVP含量的影响 总被引:3,自引:0,他引:3
目的:清热中药大多具有一定的解热作用,为探讨其解热作用机理,我们选用典型的清热中药黄芩,银花,连翘组成清热方,从体温调节中枢神经介质方面来研究其解热作用机制。方法;选用Wistar大鼠,按体重随机分作3组,背部皮下注射酵母混悬液制造发热模型,给药组灌服清热方颗粒剂,模型组予等量饮用水,正常对照组不作处理,给药2h后断头取脑,用放免方法检测大鼠下丘脑组织中AVP含量。结果:模型组大鼠体温和下丘脑组织 相似文献
644.
645.
Atara Posner Owen WJ Prall Tharani Sivakumaran Dariush Etemadamoghadam Niko Thio Andrew Pattison Shiva Balachander Krista Fisher Samantha Webb Colin Wood Anna DeFazio Nicholas Wilcken Bo Gao Christos S Karapetis Madhu Singh Ian M Collins Gary Richardson Christopher Steer Mark Warren Narayan Karanth Gavin Wright Scott Williams Joshy George Rodney J Hicks Alex Boussioutas Anthony J Gill Benjamin J Solomon Huiling Xu Andrew Fellowes Stephen B Fox Penelope Schofield David Bowtell Linda Mileshkin Richard W Tothill 《The Journal of pathology》2023,259(1):81-92
Cancer of unknown primary (CUP) is a syndrome defined by clinical absence of a primary cancer after standardised investigations. Gene expression profiling (GEP) and DNA sequencing have been used to predict primary tissue of origin (TOO) in CUP and find molecularly guided treatments; however, a detailed comparison of the diagnostic yield from these two tests has not been described. Here, we compared the diagnostic utility of RNA and DNA tests in 215 CUP patients (82% received both tests) in a prospective Australian study. Based on retrospective assessment of clinicopathological data, 77% (166/215) of CUPs had insufficient evidence to support TOO diagnosis (clinicopathology unresolved). The remainder had either a latent primary diagnosis (10%) or clinicopathological evidence to support a likely TOO diagnosis (13%) (clinicopathology resolved). We applied a microarray (CUPGuide) or custom NanoString 18-class GEP test to 191 CUPs with an accuracy of 91.5% in known metastatic cancers for high–medium confidence predictions. Classification performance was similar in clinicopathology-resolved CUPs – 80% had high–medium predictions and 94% were concordant with pathology. Notably, only 56% of the clinicopathology-unresolved CUPs had high–medium confidence GEP predictions. Diagnostic DNA features were interrogated in 201 CUP tumours guided by the cancer type specificity of mutations observed across 22 cancer types from the AACR Project GENIE database (77,058 tumours) as well as mutational signatures (e.g. smoking). Among the clinicopathology-unresolved CUPs, mutations and mutational signatures provided additional diagnostic evidence in 31% of cases. GEP classification was useful in only 13% of cases and oncoviral detection in 4%. Among CUPs where genomics informed TOO, lung and biliary cancers were the most frequently identified types, while kidney tumours were another identifiable subset. In conclusion, DNA and RNA profiling supported an unconfirmed TOO diagnosis in one-third of CUPs otherwise unresolved by clinicopathology assessment alone. DNA mutation profiling was the more diagnostically informative assay. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 相似文献
646.
Sanskar Ranglani Joey Ward PhD Naveed Sattar PhD Rona J. Strawbridge PhD Donald M. Lyall PhD 《Diabetes, obesity & metabolism》2023,25(11):3136-3143